- Oregon Health & Science University (OHSU) researchers have developed a new method called scSurvival to predict cancer patient survival by analyzing molecular data from individual tumor cells. This groundbreaking tool offers a more precise prognosis than traditional methods.
- As reported by OHSU News, scSurvival identifies specific cell populations within a tumor that are linked to patient outcomes, moving beyond methods that average signals across an entire tumor. This allows for the pinpointing of harmful or helpful cell populations driving disease progression.
- The findings were published in Cancer Discovery and presented at the American Association for Cancer Research conference. ScienceBlog.com highlighted that this is the first single-cell survival analysis directly linking individual tumor cells to patient outcomes.
- According to the NIH, scSurvival is a machine learning framework that uses large-scale data at single-cell resolution to identify high-risk patients and the tumor cells linked to that risk. This NIH-funded study tested the model on clinical data from over 150 cancer patients.
- While not yet for clinical use, researchers believe scSurvival could eventually help doctors identify high-risk patients and support the development of more precise, targeted cancer therapies. The open-source scSurvival program and its tutorials are freely available.
- As stated by Tao Ren, a co-lead author from OHSU, "This is the first kind of single-cell survival analysis that directly links individual tumor cells to patient outcomes". This approach helps solve a long-standing problem in cancer research by revealing which cells truly drive disease progression.
scSurvival: New Cancer Prognosis Tool
Oregon Health & Science University researchers have developed scSurvival, a groundbreaking machine learning tool that precisely predicts cancer patient survival by analyzing molecular data from individual tumor cells. This innovative, first-of-its-kind method identifies specific cell populations within tumors linked to patient outcomes, offering the potential to revolutionize targeted therapies and identify high-risk patients.
Reporting Sources
5
Report an issue with this article
Please sign in to report issues with this article.
Live discussion about this article
Comments
Comments are disabled for this article.
